The Relationship between Serum Uric Acid Level and Pulmonary Artery Hypertension in Patients with Chronic Renal Failure

Document Type : Original Article

Authors

1 Department of Internal Medicine, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran

2 Department of Nephrology, Nephrology Research Center, Tehran University of Medical Sciences, Tehran, Iran

3 Iranian Tissue Bank and Research Center, Imam Khomeini Hospital Complex, Tehran, Iran

4 Cardiology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Background and aim: Uric Acid is the final production of purine metabolism. The serum concentration of this substance is related to purine metabolism and renal clearance. Pulmonary hypertension (PH) in patients with CKD may be induced or aggravated by left ventricular (LV) disorders. The presence of risk factors typical to CKD is including volume overload, an arteriovenous fistula, sleep-disordered breathing. Exposure to dialysis membranes, endothelial dysfunction, vascular calcification and stiffening, and severe anemia.
Materials and methods: In this study relation between Uric Acid levels and PH in 70 patients with non-dialysis renal failure (41 females, 29 males) with a mean age of 61.71±12.44 years were assessed. The required information is extracted from the patients' records based on the questionnaire. Finally, the results are analyzed according to the SPSS program.
Results: PH was defined as a PASP ≥ 35 mmHg by echocardiography. 36 CKD patients had PH (51.4%). Average Uric Acid levels in patients with PH were significantly higher than healthy controls (p = 0.003). For 1mmHg increase Uric Acid, 0.94 mmHg in pulmonary artery pressure level will increase. There was no significant difference between patients with PH and patients without PH according to age, gender, BMI, MAP, GFR, EF, RV size & function, LV diastolic dysfunction, SMRV, and TAPSE.
Conclusion: Control of high Uric Acid levels and the treatment of risk factors of PH for prevention PH seems reasonable.

Keywords

Main Subjects


  1. Gertler MM, Garn SM, Levine SA. Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med 1951; 34: 1421-3.
  2. Anker SD, Doehner W, Rauchhaus M, et al.Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003; 107:1991-7.
  3. Oya H, Nagaya N, Satoh T, et al. Hemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome. Heart 2000; 84:53-8.
  4. Braghiroli A, Sacco C, Erbetta M, Ruga V, and Donner CF, Overnight urinary acid: creatinine ratio for detection of sleep hypoxia: Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure. Am Rev Respir Dis 1993; 148:173 -8.
  5. Lawrence G. Rudski, MD, FASE, Chair, Wyman, et al Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography Endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23:698.
  6. Abdelwhab S and Elshinnawy S .Pulmonary hypertension in chronic renal failure patients. Am. J. Nephrol. 2008; 28: 990-997.
  7. Kiykim AA, Horoz M, Ozcan T, Yildiz I, et al. Pulmonary hypertension in hemodialysis patients without arteriovenous fistula: the effect of dialyzer composition. Ren. Fail. 2010; 32: 1148-1152.
  8. Sakaguchi Y, Shoji T, Kawabata H, Niihata K, et al. High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study. Clin. J. Am. Soc. Nephrol.2011; 6: 995-1000.
  9. Zoccali C. The endothelium as a target in renal diseases. J. Nephrol. 20 (Suppl 12) 2007; S39-S44.
  10. Buemi M, Senatore M, Gallo GC, Crasci E, et al. Pulmonary hypertension and erythropoietin. Kidney Blood Press Res. 32007; 0: 248-252.
  11. Havlucu Y, Kursat S, Ekmekci C and Celik P. Pulmonary hypertension in patients with chronic renal failure. Respiration . 2007; 74: 503-510.
  12. Nagaya N, Uematsu M, Satoh T, Kyotani S, Sakamaki F, Nakanishi N, et al.Serum uric acid levels correlate with the severity and mortality of primary pulmonary hypertention.Am Respir Crit Care Med 1999;160(2):487-492.
  13. Bendayan D, Shitrit D, Ygla M, Huerta M, Fink G, Kramer MR. Hyperuricemia as a prognostic factor in pulmonary arterial hypertension. Respir Med, 2003; 97(2):130-133.
  14. Yang Q, Bao. Pulmonary hypertension in patients with stage 1-3 chronic kidney disease. Genetic and molecular research. 2014; 13(3):5695-5703.
  15. Zhang C, Wang M, Ma L. Relation between serum uric acid levels and ventricular function in patients with idiopathic pulmonary hypertension. Exp Clin Cardiol, Vol 18, 2013, 37.
  16. Issa N, Krowka MJ, Griffin MD, Hickson LJ, et al. Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation (2008); 86: 1384-1388.
  17. K.B. Martin, J.R. Klinger, S.I.S. Rounds Pulmonary arterial hypertension: new insights and new hope Respirology, 11 (1) (2006), pp. 6–17.
  18. Rudski LG, Lai WW, Afilalo J, Hua L, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr. 2010; 23: 685-713.
  19. Yigla M, Fruchter O, Aharonson D, Yanay N, et al. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int. 2009; 75: 969-975.
  20. Zhilian Li, Xinling Liang, Shuangxin Liu, Zhiming Ye, et al (2015). Pulmonary Hypertension: Epidemiology in Different CKD Stages and Its Association with Cardiovascular Morbidity. Department of Nephrology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China, 5100800.
Volume 1, Issue 2
June 2019
Pages 23-25
  • Receive Date: 04 June 2019
  • Revise Date: 23 June 2019
  • Accept Date: 25 June 2019
  • First Publish Date: 25 June 2019